Trial of (+)-Cyanidanol-3 in Patients with Hepatitis B Chronic Liver Disease | Zendy

P. W. N. Keeling | Zendy; Luis Viola | Zendy; Michael G. Anderson | Zendy; J H Marigold | Zendy; J. C. Macartney | Zendy; F.J. Paradinas | Zendy; I M Murray-Lyon | Zendy; R. P. H. Thompson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Trial of (+)-Cyanidanol-3 in Patients with Hepatitis B Chronic Liver Disease

Author(s) -

P. W. N. Keeling,

Luis Viola,

Michael G. Anderson,

J H Marigold,

J. C. Macartney,

F.J. Paradinas,

I M Murray-Lyon,

R. P. H. Thompson

Publication year - 1986

Publication title -

journal of the royal society of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.38

H-Index - 81

eISSN - 1758-1095

pISSN - 0141-0768

DOI - 10.1177/014107688607900809

Subject(s) - medicine , chronic liver disease , gastroenterology , chronic hepatitis , hepatitis , liver disease , disease , hepatitis b , immunology , cirrhosis , virus

A double-blind controlled trial of 12 months' treatment with (+)-cyanidanol-3 was carried out in 26 patients with chronic hepatitis B liver disease. Treatment did not improve liver blood tests nor histological appearances of the liver, but there was a trend towards reduction of serum titres of hepatitis B surface antigen.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research